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Abstract
Background: Foot pain is a common problem affecting up to 1 in 5 adults and is known to adversely affect activities of
daily living and health related quality of life. Orthopaedic footwear interventions are used as a conservative treatment for
foot pain, although adherence is known to be low, in part due to the perception of poor comfort and unattractiveness
of the footwear. The objective of this trial was to assess the efficacy of flip-flop style footwear (Foot Bio-Tec©) with a
moulded foot-bed in reducing foot pain compared to participant’s usual footwear.
Methods: Two-arm parallel randomised controlled trial using computer generated random allocation schedule at an
Australian university podiatry clinic. 108 volunteers with disabling foot pain were enrolled after responding to an
advertisement and eligibility screening. Participants were randomly allocated to receive footwear education and
moulded flip-flop footwear to wear as much as they were comfortable with for the next 12 weeks (n = 54) or footwear
education and instructions to wear their normal footwear for the next 12 weeks (n = 54). Primary outcome was the pain
domain of the Foot Health Status Questionnaire (FHSQ). Secondary outcomes were the foot function and general foot
health domains of the FHSQ, a visual analogue scale (VAS) for foot pain and perceived comfort of the intervention
footwear.
Results: Compared to the control group, the moulded flip-flop group showed a significant improvement in the primary
outcome measure of the FHSQ pain domain (adjusted mean difference 8.36 points, 95 % CI 5.58 to 13.27, p < 0.01).
Statistical and clinically significant differences were observed for the secondary measure of foot pain assessed by a VAS
and the FSHQ domains of foot function and general foot health. None of the participants reported any pain or
discomfort from the intervention footwear and six (footwear group = 4) were lost to follow up.
Conclusions: Our results demonstrate that flip-flop footwear with a moulded foot-bed can have a significant effect on
foot pain, function and foot health and might be a valuable adjunct therapy for people with foot pain.
Trial registration: ACTRN12614000933651. Retrospectively registered: 01/09/2014.
Keywords: Shoes, Pain measurement, Health status indicators
Background
Foot pain is widely acknowledged to be a common prob-
lem. A recent systematic review involving 75,000 adults
found that approximately 1 in 5 people over 45 years of
age experience ‘frequent’ foot pain [1], and a UK survey of
3,417 adults reported 24 % of females and 20 % of males
had foot pain in the last month lasting at least 1 day [2].
In the middle aged and older population, foot pain is more
prevalent in females, the forefoot and toes are the most
common site of pain, and in two thirds of cases this re-
sults in a moderate disability in an aspect of daily life [1].
The community burden of foot pain is high and is known
to adversely affect activities of daily living [2], reduce
health related quality of life (QOL) [3], impair balance and
functional ability in community dwelling older people [4],
and increase risk of falls in older people [5, 6].
Footwear interventions are widely used as a conservative
treatment method for foot pain [7, 8]. The orthopaedic
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footwear usually recommended is a closed in lace-up style
shoe and adherence to this intervention is known to be as
low as 22 %, with perceived poor comfort and unattract-
iveness of the footwear cited as the main-reasons for non-
adherence [8, 9]. Flip-flop style footwear has not been
considered as a treatment modality for foot pain as it is
believed to provide less support, protection, cushioning
and motion control compared to closed-in shoes [10–12].
The introduction of new design features in flip flops such
as moulded foot-beds, increased sole thickness and a heel-
to-forefoot slope allows them to provide some of the func-
tionality of closed in shoes [13, 14]. Despite the popularity
of flip-flop style of footwear, there is very limited evidence
regarding the effect these design features have on foot
pain and foot function, with only one study investigating
the use of a contoured sandal for treating plantar heel pain
[15]. This study found the sandal provided a similar bene-
ficial reduction in pain compared to a contoured shoe in-
sert, and that both the sandal and the shoe insert provided
a significant reduction in pain compared to a flat flip flop.
The aim of this study was to investigate the efficacy of
flip-flop style footwear with a moulded foot-bed in redu-
cing foot pain and improving function compared to usual
footwear in adults with disabling foot pain. We also
assessed the effect of the footwear on perceptions of gen-
eral foot health and comfort.
Methods
Design and trial registration
The study was a two-arm parallel group randomised
controlled trial with a 12 week follow up period and is
reported using CONSORT guidelines [16]. The trial has
been registered on the Australian New Zealand Clinical
Trials Registry (ACTRN12614000933651). All participat-
ing patients gave their informed consent. Research was
conducted at the University of Newcastle Podiatry Clinic
at Wyong Hospital.
Randomisation and blinding
After enrolment participants completed a set of baseline
questionnaires to determine their foot pain and foot
function. Participants were then randomised into either
an intervention group that received a pair of test foot-
wear and footwear education or a control group that re-
ceived footwear education only. Prior to recruitment AS
prepared sequentially numbered, opaque sealed enve-
lopes containing a computer generated random alloca-
tion schedule with mixed block lengths of four and six
participants. The person administering the intervention
(VC) enrolled participants and assigned participants to
groups by selection of the next sequential envelope. Stat-
istical analysis was performed independently by MS. All
outcome data was collected using self-reported question-
naires completed by the participants. The participants
and the person administering the intervention (VC) were
not blinded as they were aware of what type of shoe they
were wearing. The person conducting data analysis (MS)
was blinded to group allocation.
Participants
Potential participants were recruited on a volunteer basis
via advertising flyers at the University of Newcastle
Central Coast Campus and the University of Newcastle
Podiatry Clinic at Wyong Hospital. Inclusion criteria
were adults, 18 years of age and over with disabling foot
pain, which was defined as current foot pain located
below the level of the ankle joint which prevented them
from doing at least one of their normal activities. Exclu-
sion criteria were history of foot amputation, current
foot pain due to arterial insufficiency, venous insuffi-
ciency or peripheral neuropathy of any cause, a neurode-
generative disorder or a history of two or more falls in
the previous 12 months. All potential participants re-
ceived a participant information statement and were
screened via a short phone call to ensure inclusion and
exclusion criteria were met. Any participants reporting
medical history associated with the exclusion criteria relat-
ing to peripheral arterial disease, venous insufficiency or
peripheral neuropathy underwent additional screening in-
cluding visual examination, continuous wave Doppler
and/or a four site 10 g monofilament test [17, 18]. Pres-
ence of a monophasic waveform or loss of sensation at
one site was considered indicative of pathology [17, 18]
and the potential participant was excluded. History of falls
in the last 12 months was confirmed through verbal ques-
tioning. At their first appointment participants completed
the consent form before being enrolled in the trial.
Intervention
Participants in the intervention group were fitted with a
pair of flip flops (Foot Bio-Tec©, Silverwater, NSW,
Australia) with a moulded foot-bed, heel cup and wide
straps (Fig. 1), and asked to wear the footwear as much
as they were comfortable with for the next 12 weeks.
Participants in the control group were asked to wear
their usual footwear for the next 12 weeks. Both the
control and intervention groups received general advice
on footwear including choosing footwear of an appropri-
ate size and fit, with firm fastening, low heel height and
slip-resistant soles. Participants who received the test
footwear were asked to complete a daily footwear diary
to record how often and for how long they wore the
intervention footwear. At the conclusion of the trial
participants were asked if they had undertaken any
other treatment for their foot pain during this time
and if the intervention footwear had caused any pain
or discomfort.
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Outcomes
All outcome data was collected using self-reported ques-
tionnaires completed by the participants. The partici-
pants were not blinded as they were aware of what type
of shoe they were wearing.
Primary outcome measure
The primary outcome measure was the foot pain domain
of the Foot Health Status Questionnaire (FHSQ) recorded
at baseline and the 12 week follow-up. The FHSQ mea-
sures foot specific health related QOL and has been shown
to demonstrate high content, criterion and construct valid-
ity as well as clinical utility and reliability [19, 20]. The
FHSQ measures four subscales of foot health: foot pain,
foot function, footwear and general foot health. Scores are
converted to a scale from 0, which represents the poorest
state of foot health, to 100 which signifies optimum foot
health. The minimal important difference (MID) value
used for this domain was 14 points [21].
Secondary outcome measures
Secondary outcome measures, recorded at baseline and
the 12 week follow-up, were the FHSQ domains of foot
function and general foot health as described above, plus
current foot pain using a 100 mm visual analogue scale
which is widely used due to its simplicity and adaptabil-
ity [22, 23] and has been validated as a reliable generic
pain measure [24]. The instructions on the VAS stated
‘Please mark the position on the line that represents
how much foot pain you are currently experiencing. The
far left end indicates ‘No pain’ and the far right end indi-
cates ‘Worst pain imaginable”. Foot pain intensity on the
VAS is rated from no pain (score of 0) to worst imagin-
able pain (score of 100). Minimal important difference
(MID) values used for these measures were 9 mm for
pain on the VAS and with the FHSQ, 7 points for foot
function and 9 points for general foot health [21].
Perceived comfort of the intervention footwear was also
recorded at 12 weeks following the intervention. This was
measured using a VAS based survey that collected data on
the comfort level of the heel, midfoot and forefoot and the
overall comfort of the footwear. The instructions on the
VAS stated ‘Please mark on the lines below to indicate
how you would rate your shoes for each of the compo-
nents of the shoe. The further to the right you mark the
line the more comfortable you find that aspect of the
shoe.’ Comfort was rated from 0 mm (not comfortable at
all) to 100 mm (most comfortable condition imaginable).
It has been reported previously that VAS scales are reliable
in assessing footwear comfort [25].
Sample size
We based the a priori sample size calculations on a min-
imal important difference of 14 points for the foot pain
domain of the FHSQ [21]. Assuming a standard deviation
of 20.5 points based on the average standard deviation of
previously reported baseline FHSQ pain measures [26], a
power of 90 % and an alpha 0.05 and allowing for 20 % at-
trition rate, 54 participants per group were required mak-
ing a total sample size of 108 participants.
Statistical analysis
Statistical analysis was undertaken using SPSS version
21 (IBM Corp, Chicago, Illinois) by a researcher blinded
to group allocation. Statistical significance was delimited
at P < 0.05. Data were assessed for normality of distribu-
tion, internal consistency, homogeneity of variance and
linearity. The difference between groups at follow-up for
the primary outcome (foot pain domain of the FHSQ)
was analysed with analysis of covariance (ANCOVA)
using a linear regression approach. We pre-specified that
the baseline measure of FHSQ pain was used as the only
covariate in the analysis. Similarly for the secondary out-
come measures of FHSQ function, FHSQ general foot
Fig. 1 Test Footwear: Foot Bio-Tec© Orthotic footwear
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health and the VAS for foot pain, ANCOVA using a linear
regression approach was conducted. The baseline mea-
sures of FHSQ function, FHSQ general foot health and
the VAS for foot pain were the only covariates used in
each respective analysis. Cohen’s d was used to calculate
effect sizes for the primary and secondary outcomes. An
effect size of greater than or equal to 0.8 was considered
to represent a large clinical effect, 0.5 a moderate effect
and 0.2 a small effect [27]. Comfort ratings were calcu-
lated as a mean score for each category of the survey.
Data were analysed by intention to treat. Missing data
were estimated in SPSS using multiple imputation with a
regression method for all continuous variables [28]. Ten
imputed data sets were generated for analysis and the re-
sults of each combined. The data contained only mono-
tone missing patterns with six participants lost to follow
up (four from the intervention group, two from the con-
trol group) representing 5.5 % of the data.
Results
One hundred and eight participants were recruited
between April and October 2014. Participants’ pro-
gression through the trial is shown in a CONSORT
diagram in Fig. 2. Participant baseline characteristics
are included in Table 1. Mean hours of flip-flop use
by the intervention group over the 12 week period
was 183.03 h (SD 75.69 h) which equates to approxi-
mately 15.25 h per week.
None of the participants reported any pain or discomfort
from wearing the intervention footwear. Fifty (94 %) partici-
pants in the intervention group submitted their footwear
diary and the comfort questionnaire at the completion of
the trial. Both groups reported the use of co-interventions
during the trial period. The most common co-interventions
were analgesic use (35 % of control group and 30 % of
intervention group) and further podiatry treatment includ-
ing general treatment, taping and stretching (22 % of con-
trol group and 26 % of intervention group).
Primary outcome
When compared to the control group, participants in the
flip-flop intervention group demonstrated statistically sig-
nificant improvements in pain measured at 12 weeks by
the foot pain domain of the FHSQ (adjusted mean differ-
ence 9.6, 95 % CI:5.5 to 13.3) with a moderate effect size
(Cohen’s d 0.64) (Table 2). The improvement in pain for
the foot pain domain of the FHSQ was less than the MID
for a clinically meaningful difference in pain levels.
Secondary outcomes
Compared to the control group, participants in the
intervention group showed a statistically significant
Fig. 2 Flow of participants through the randomised controlled trial
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improvement in pain on the VAS at 12 week follow-up
with an adjusted mean difference of 9.37 mm and a
small effect size (Table 2). They also showed statistically
significant improvements in foot function as measured
by the FHSQ domain of foot function as well as the do-
main of general foot health, with effect sizes approaching
moderate (Table 2). The between group differences in
the scores for all the secondary outcome measures
exceeded the MIDs for these scales (Table 2).
Overall comfort of the intervention footwear measured
by the VAS scale was rated at 72.1 points (SD 12.3) with
a range 43.0 to 95.0. Heel comfort was rated at 67.6
points (SD 13.6) with a range of 42.0 to 93.0. Forefoot
comfort was rated at 69.2 points (SD 12.2) with a range
of 32.0 to 90.0 and the midfoot comfort was rated a 74.0
points (SD 14.9) with a range of 34.0 to 100.
Discussion
This trial demonstrated that the use of a flip-flop with a
moulded foot-bed resulted in a statistical reduction in
pain measured by the FHSQ compared to a group not
using a contoured flip-flop. These results are similar to a
previous trial by Vincenzio et al. [15] who reported both
statistically and clinically important improvements in
pain and function following the use of a contoured san-
dal compared to a flat flip-flop. The reduced effect on
pain demonstrated in this present trial compared to that
of Vincenzio et al. [15] may have been due to the control
condition being the participants’ own footwear rather
than a flat flip-flop, a wide inclusion criteria for this trial,
a relatively low adherence to the intervention or short
trial duration for foot pain that was frequently chronic
in nature. However, it should be noted that while there
is no normative data for the questionnaires used in both
these trials, the post-trial scores are noticeably less than
the possible maximum indicating that this footwear
intervention is an adjunct rather than a primary treat-
ment for foot pain.
This study also demonstrated a statistically significant
improvement in secondary measures of foot function,
general foot health and foot pain measured by the VAS.
All of these measures also showed clinically significant
between group differences, based on validated minimal
important differences for these assessment tools [21].
Overall the use of the flip flops demonstrated a positive
effect on perceptions of foot pain and function. How-
ever, it should be noted that as secondary outcome mea-
sures it is possible that this study was underpowered to
Table 1 Participant characteristics at baseline
Characteristic Control (n = 54) Flip-Flop (n = 54)
Sex Male 23 (43) Male 27 (50)
Female 31 (57) Female27 (50)
Age (mean ± SD in years) 49.1 ± 16.9 48.6 ± 14.1
Duration of foot pain
(mean ± SD in weeks)
71.3 ± 179.3 63.5 ± 163.4
Location of pain
Rearfoot 11 (20) 15 (28)
Midfoot 12 (22) 11 (20)
Forefoot 22 (41) 18 (33)
General foot 9 (17) 10 (19)
Does regular exercise 49 (87) 47 (85)
Medical Conditionsa
Diabetes 3 (5.5) 8 (14.8)
Osteoarthritis 12 (22.2) 10 (18.5)
High blood pressure 24 (44.4) 23 (42.6)
Heart disease 4 (7.4) 5 (9.3)
Lung disease 6 (11.1) 2 (3.7)
Hormone replacement therapy 0 (0) 3 (5.5)
Hypercholesterolemia 16 (29.6) 23 (42.6)
Rheumatoid arthritis 1 (1.9) 2 (3.7)
Back pain 8 (14.8) 11 (20.4)
Depression 5 (9.3) 5 (9.3)
Values are number (%) unless otherwise stated
aSome participants reported multiple medical conditions
Table 2 Primary and secondary outcome measures of pain and function at baseline and 12 week follow-up. Values are means
(standard deviations) unless otherwise stated
Measure Intervention Group Control group Adjusted mean
difference (95 % CI)
P Value Effect size
(Cohen’s d)Baseline Follow-up Baseline Follow-up
Primary Outcome
FHSQ Painb 52.6 (15.7) 61.5 (16.4) 51.1 (16.7) 50.7 (17.6) 9.6 (5.5 to 13.3) <0.01 0.64
Secondary Outcomes
Pain VAS (mm)c 55.7 (17.9) 45.4 (19.6) 52.7 (18.3) 51.8 (20.5) −9.4a (5.6 to 13.2) <0.01 0.33
FHSQ Functionb 60.7 (20.4) 68.1 (19.4) 60.0 (20.2) 59.1 (21.4) 8.4a (4.8 to 11.7) <0.01 0.44
FHSQ General Foot Healthb 26.5 (27.9) 36.7 (30.7) 23.8 (27.0) 25.1 (27.0) 8.9a (0.6 to 13.3) <0.01 0.41
ameets minimal important difference level for a clinically meaningful difference
bFHSQ_Foot Health Status Questionnaire (0 = “worst foot health,” 100 = “best foot health”)
cVAS_Visual Analog Scale (0 to 100 - higher values indicate greater levels of pain)
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detect significant differences between groups, increasing
the risk of a Type 1 error.
This study did not record any measures of foot and
lower limb kinetics and kinematics. However, changes in
variables such as plantar pressures and motion control
may have contributed to the improvements in pain. High
plantar pressures during gait have been linked to the de-
velopment of foot pain in a variety of populations [5, 29]
and the use of traditional flat flip-flops have been shown
to produce higher peak plantar pressures than athletic
shoes [11]. Conversely, contoured orthoses have been
shown to decrease peak pressure under the rearfoot and
forefoot by increasing the maximum force and contact
area under the midfoot [30, 31]. It is plausible that the
moulded foot-bed in the intervention flip-flop may act
in the same way to assist in the reduction and redistribu-
tion of plantar pressures, and so reduce high forefoot
pressure which has been associated with foot pain [31].
While research investigating the change in gait kinemat-
ics and kinetics with flip-flop style footwear is limited
there is some evidence to suggest that flip-flop style
footwear results in changes to walking parameters such
as shortened stride length [32] and slower walking
speeds [33]. Lower plantar pressures have been docu-
mented with slower walking speeds in both younger and
older adults [34] as well as with decreased stride length
[35], and it is possible that these changes may have con-
tributed to the reduction in reported pain levels. The
test flip-flop footwear also featured a small bevel to the
anterior and posterior sole of the shoe, effectively mak-
ing a rocker sole, which has been shown to reduce fore-
foot plantar pressures and restrict sagittal plane range of
motion in painful joints [36]. It has also been reported
that many people wear shoes that are too narrow and
short for their foot which can contribute to foot pain by
increasing the risk of ulceration, callus, corns and toe
deformity [37, 38]. The open style of the intervention
flip-flops may have added to the reduction in foot pain
through better accommodation of the foot and reduction
in pressure on bony prominences.
The footwear was well tolerated by the participants in
the intervention group with high comfort levels reported
for both overall comfort as well as perceived comfort in
the separate sub regions of the forefoot, midfoot and
rearfoot. Shoe fit is known to influence levels of per-
ceived shoe comfort as tightly fitting shoes can result in
uncomfortable foot compression, while loose fitting
shoes can lead to soft tissue injury by slippage and fric-
tion [39]. The contoured midsole and the open style of
the intervention flip-flops may have contributed to a
better perceived fit and the high reported comfort levels.
In addition, the potential redistribution of plantar pres-
sure with the moulded footwear may also have increased
perceived comfort as high forefoot pressure and smaller
contact area in the midfoot has been associated with poor
footwear comfort ratings [40]. Further, arch comfort has
been identified by one study as the most important influ-
ence in overall footwear comfort [25] and this area re-
corded the highest comfort level rating in our study.
Limitations
The results of this study need to be considered in light
of several limitations. It was not possible for participants
to be blinded as they were asked to wear either their
own shoes or the intervention shoes for 12 weeks. This
may have resulted in the participants in the intervention
group having a more positive response to the interven-
tion. This may have led to a placebo effect, ascertain-
ment bias or resentful demoralisation which could have
impacted the estimate of the treatment effect provided
by the intervention [41].
Despite the reported high levels of tolerance and com-
fort in wearing the moulded foot-bed flip-flops, the ad-
herence to the intervention was relatively low with
participants wearing the device for only 15 h per week.
This possibly reflects the limitation of the intervention
footwear with its open style design which makes it unsafe,
or inappropriate in some workplace and social situations
and that the weather influences choice of footwear. While
this clearly limits the application of this modality it is pos-
sible that a larger magnitude in pain reduction may be
achieved with a sub group of people whose lifestyle allows
more frequent usage of open footwear.
As previously stated, it is possible the full extent of
pain reduction was not achieved in the 12 week course
of the trial and that longer periods would have created
greater changes in foot pain and function. However it is
also possible that the reductions in foot pain and im-
provements in foot function may have diminished with a
longer duration as this has been shown to occur with
orthotic use for people with plantar fasciitis [42]. The
wide range of conditions causing foot pain for partici-
pants in this trial may also have affected the results of
this study as certain conditions such as arthritis may re-
spond differently to footwear than conditions that tend
to be more transient such as plantar fasciitis [14, 43]. As
any type of foot pain was included it is also possible that
conditions associated with poor fit of enclosed shoes
responded well to open style footwear and the reduc-
tions in pain were not related to function of the foot-
wear but lack of pressure. Even if this is the case, the
reduction in pain is still relevant as poor fitting shoes
are a major contributor to foot pain in the community
[44]. Further research would help to determine path-
ology explicit responses to this type of footwear. In
addition, the method of data collection required partici-
pants to self-report their daily footwear use. While self-
report is a simple and inexpensive method of reporting
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it has been associated with over-estimation in medica-
tion and exercise trials [45, 46].
Conclusions
This study was undertaken to assess the effectiveness of
the flip-flop footwear with a moulded foot-bed for redu-
cing foot pain, improving foot function and perception
of general foot health and to determine the perceived
comfort of test footwear. Our results show that specia-
lised flip-flop footwear had a statistically significant ef-
fect on foot pain but the reduction in pain did not meet
the minimal important difference for a clinical effect.
However, the trial demonstrated global improvements in
all aspects of pain and function and perceived foot
health indicating that flip flops with a moulded foot bed
might be a valuable adjunct therapy for people with foot
pain. Features of the test flip-flop such as a moulded
foot-bed, bevel and open style may be contributing fac-
tors to the reduction in foot pain.
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